Innova Captab Share Price | Innova Captab Stock Screener
INNOVACAP
Pharmaceuticals
Share Price NSE
₹950.45
▼
-17.50 (-1.81%)
Share Price BSE
₹943.75
▼
-23.25 (-2.40%)
As of July 24, 2026, the Innova Captab share price (NSE: INNOVACAP) is ₹950.45 on NSE and ₹943.75 on BSE, down 1.81% from the previous close, with shares trading between ₹934.55 and ₹965.90, and a 52-week range of ₹644.75–₹1,011.30.
Analyse INNOVACAP share price charts and track historical price performance.
Use the Innova Captab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Innova Captab Market Cap
₹5,605.18 Cr.
INNOVACAP P/E Ratio (TTM)
39.76
Innova Captab P/B Ratio
5.14
EPS (TTM)
₹24.63
Dividend Yield
0.20%
Debt to Equity
0.33
INNOVACAP 52 Week High
₹1011.30
Innova Captab 52 Week Low
₹644.75
Operating Margin
15.00%
Profit Margin
8.46%
INNOVACAP Revenue (TTM)
₹449.00
EBITDA
₹67.00
Net Income
₹38.00
Total Assets
₹1,837.00
Total Equity
₹1,091.00
Innova Captab Share Price Chart
Screen Innova Captab share price with an interactive chart. Analyse INNOVACAP price trends and volatility across different timeframes.
Innova Captab Company Profile - Fundamental Screener
Screen Innova Captab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INNOVACAP shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0DUT01020
Innova Captab Balance Sheet Screener
Screen INNOVACAP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,837 | 1,580 | 1,321 | 704 | 576 | 370 | 245 | 0 |
| Current Assets | 923 | 696 | 580 | 443 | 379 | 271 | 171 | 0 |
| Fixed Assets | 842 | 830 | 358 | 183 | 183 | 79 | 73 | 0 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 252 | 268 | 225 | 150 | 72 | 10 | 14 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,091 | 959 | 831 | 277 | 209 | 145 | 110 | 0 |
| Share Capital | 57 | 57 | 57 | 48 | 12 | 12 | 12 | 0 |
| Reserves & Surplus | 1,034 | 902 | 774 | 229 | 197 | 133 | 98 | 0 |
Innova Captab Income Statement Screener - Profit & Revenue Analysis
Screen Innova Captab income statement and profit fundamentals.
Analyze INNOVACAP quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Innova Captab share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 449 | 452 | 385 | 356 | 318 | 321 | 320 | 296 | 268 | 305 | 286 | 234 | 244 | 245 | 244 |
| Expenses | 383 | 381 | 329 | 299 | 267 | 270 | 269 | 252 | 225 | 258 | 243 | 202 | 214 | 208 | 211 |
| EBITDA | 67 | 71 | 56 | 57 | 51 | 51 | 52 | 44 | 44 | 47 | 44 | 32 | 29 | 37 | 33 |
| Operating Profit % | 15.00% | 15.00% | 14.00% | 15.00% | 15.00% | 15.00% | 16.00% | 14.00% | 15.00% | 15.00% | 14.00% | 13.00% | 11.00% | 14.00% | 13.00% |
| Depreciation | 11 | 11 | 11 | 11 | 10 | 5 | 5 | 5 | 3 | 5 | 5 | 3 | 3 | 3 | 3 |
| Interest | 5 | 4 | 6 | 3 | 2 | 0 | 0 | 0 | 1 | 7 | 9 | 5 | 5 | 6 | 5 |
| Profit Before Tax | 51 | 56 | 39 | 43 | 39 | 46 | 47 | 39 | 40 | 35 | 30 | 25 | 21 | 28 | 25 |
| Tax | 13 | 14 | 10 | 12 | 10 | 11 | 12 | 10 | 11 | 10 | 7 | 7 | 4 | 9 | 6 |
| Net Profit | 38 | 42 | 30 | 31 | 30 | 34 | 35 | 30 | 29 | 25 | 23 | 18 | 17 | 20 | 19 |
| EPS | 6.65 | 7.37 | 5.18 | 5.42 | 5.17 | 5.97 | 6.12 | 5.15 | 5.02 | 4.39 | 4.77 | 3.67 | 3.59 | 4.08 | 3.91 |
Innova Captab Cash Flow Screener - Liquidity Fundamentals
Screen INNOVACAP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 117 | 64 | 146 | 67 | 59 | 42 | 31 | 19 |
| Investing Activities | -107 | -152 | -499 | -91 | -188 | -20 | -6 | -9 |
| Financing Activities | -22 | 92 | 361 | 27 | 125 | -19 | -23 | -9 |
| Net Cash Flow | -12 | 4 | 8 | 3 | -5 | 3 | 2 | 1 |
Innova Captab Shareholding Pattern Screener
See Innova Captab shareholding pattern with promoter, FII, and DII holdings.
Check Innova Captab promoter holding and ownership changes for INNOVACAP on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% | 50.90% |
| FII Holding | 0.23% | 0.34% | 0.34% | 0.23% | 0.08% | 0.11% | 1.94% | 1.19% |
| DII Holding | 20.14% | 19.92% | 19.76% | 19.67% | 20.17% | 20.24% | 20.77% | 21.23% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.11% | 27.22% | 27.62% | 27.71% | 27.35% | 27.22% | 25.47% | 25.80% |
| Other Holding | 1.62% | 1.62% | 1.37% | 1.49% | 1.50% | 1.53% | 0.91% | 0.88% |
| Shareholder Count | 36,965 | 35,881 | 39,996 | 41,014 | 40,245 | 38,691 | 39,396 | 35,115 |
Innova Captab Share Dividend Screener - Share Yield Analysis
Check Innova Captab dividend history with payout and yield data.
View Innova Captab dividend details including ex-dates and amounts for INNOVACAP stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹2.00 | 0.20% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Innova Captab Stock Index Membership
See which indices include Innova Captab stock.
Check INNOVACAP index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY IPO
NIFTY MICROCAP250
NIFTY TOTAL MKT
Innova Captab Market Events Screener - Corporate Actions
Get Innova Captab corporate actions including splits, bonuses, and buybacks.
Check Innova Captab stock events that may affect INNOVACAP share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-06-29 | 2026-06-29 | Annual General Meeting | NA | 9.56% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 20.86% |
| 2026-01-30 | 2026-01-30 | Dividend | ₹ 2.00 /share | 3.53% |
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -3.70% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -1.75% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 3.01% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | 8.82% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 9.28% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 12.54% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 13.66% |
| 2024-09-18 | 2024-09-18 | Annual General Meeting | NA | 16.12% |
Innova Captab Competitors Screener - Peer Comparison
Screen INNOVACAP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 470,270 | 40.90 | 61,674 | 12.69% | 11,565 | 68.02 |
| Divis Laboratories | 194,588 | 75.78 | 11,067 | 13.95% | 2,568 | 71.98 |
| Torrent Pharmaceuticals | 191,858 | 79.75 | 13,886 | 20.34% | 2,138 | 66.68 |
| Cipla | 115,764 | 29.97 | 29,045 | 2.24% | 3,870 | 52.50 |
| Zydus Life Science | 115,083 | 22.27 | 27,658 | 17.64% | 5,026 | 58.19 |
| Lupin | 115,040 | 21.47 | 29,039 | 26.75% | 5,356 | 63.60 |
| Mankind Pharma | 106,512 | 54.93 | 14,636 | 14.85% | 1,938 | 60.75 |
| Dr Reddys Laboratories | 100,736 | 24.22 | 35,059 | 3.90% | 4,158 | 32.84 |
| Aurobindo Pharma | 91,025 | 26.21 | 33,385 | 3.21% | 3,376 | 58.93 |
| Laurus Labs | 85,999 | 96.66 | 6,868 | 22.01% | 890 | 67.71 |
Innova Captab Company Announcements - News Screener
Screen INNOVACAP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-24 | Intimation Of Postponement Of The 22Nd Annual General Meeting Of The Company | - |
| 2026-06-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-05 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-06-04 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-06-04 | Reg. 34 (1) Annual Report. | - |
| 2026-06-04 | Notice Convening The 22Nd Annual General Meeting (AGM) And Submission Of Integrated Annual Report Of The Company For The Financial Year 2025-2026. | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-26 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Committee Of The Board | - |
| 2026-05-26 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Audit Committee Of The Board | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-25 | Board Meeting Outcome for Pursuant To Regulation 30 We Wish To Inform You That The Board Of Directors Of The Company At Its Meeting Held Today I.E. On Monday 25Th May 2026 Inter-Alia Considered The Reappointment Of Auditors Directors And Approval Of AGM N | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |